Antibody-mediated lung transplant is currently a rare type of rejection.

The Registry of the International Society for Heart and Lung Transplantation reported that at least 29% of 12980 lung transplant recipients in-between 2004 and 2014 had at least one rejection episode in the first year after discharge.